UK markets closed

Immuneering Corporation (IMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5100-0.1800 (-10.65%)
At close: 04:00PM EDT
1.5298 +0.02 (+1.31%)
After hours: 07:45PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
316.952
2,080
2,312
-
Cost of revenue
-
0
158.122
1,153
1,280
-
Gross profit
-
0
158.83
926.888
1,031
-
Operating expenses
Research development
42,616
41,624
36,267
26,541
15,004
-
Selling general and administrative
16,495
16,760
15,607
8,272
3,110
-
Total operating expenses
59,140
58,413
51,904
34,813
18,114
-
Operating income or loss
-59,140
-58,413
-51,745
-33,886
-17,083
-
Interest expense
-
-
-
-
0
351.302
Total other income/expenses net
1,303
1,334
216.844
-127.063
-
-
Income before tax
-54,256
-53,472
-50,514
-33,843
-17,040
-
Income tax expense
-
-
0
-307.485
-
-
Income from continuing operations
-54,256
-53,472
-50,514
-33,536
-17,040
-
Net income
-54,175
-53,472
-50,514
-33,536
-17,040
-
Net income available to common shareholders
-54,175
-53,472
-50,514
-33,536
-17,040
-
Basic EPS
-1.86
-
-1.91
-2.46
-1.26
-0.90
Diluted EPS
-1.86
-
-1.91
-2.46
-1.26
-0.90
Basic average shares
27,699
-
26,387
13,613
13,511
8,579
Diluted average shares
27,699
-
26,387
13,613
13,511
8,579